154 related articles for article (PubMed ID: 38787503)
21. Hypoxia-induced decoy receptor 2 gene expression is regulated via a hypoxia-inducible factor 1alpha-mediated mechanism.
Pei GT; Wu CW; Lin WW
Biochem Biophys Res Commun; 2010 Jan; 391(2):1274-9. PubMed ID: 20018172
[TBL] [Abstract][Full Text] [Related]
22. Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types.
Shivapurkar N; Toyooka S; Toyooka KO; Reddy J; Miyajima K; Suzuki M; Shigematsu H; Takahashi T; Parikh G; Pass HI; Chaudhary PM; Gazdar AF
Int J Cancer; 2004 May; 109(5):786-92. PubMed ID: 14999791
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) decoy receptor TRAIL-R3 is up-regulated by p53 in breast tumor cells through a mechanism involving an intronic p53-binding site.
Ruiz de Almodóvar C; Ruiz-Ruiz C; Rodríguez A; Ortiz-Ferrón G; Redondo JM; López-Rivas A
J Biol Chem; 2004 Feb; 279(6):4093-101. PubMed ID: 14623878
[TBL] [Abstract][Full Text] [Related]
24. Rel/NF-kappaB transcription factors protect against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by up-regulating the TRAIL decoy receptor DcR1.
Bernard D; Quatannens B; Vandenbunder B; Abbadie C
J Biol Chem; 2001 Jul; 276(29):27322-8. PubMed ID: 11350953
[TBL] [Abstract][Full Text] [Related]
25. Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.
Vigneswaran N; Baucum DC; Wu J; Lou Y; Bouquot J; Muller S; Zacharias W
BMC Cancer; 2007 Jun; 7():108. PubMed ID: 17592646
[TBL] [Abstract][Full Text] [Related]
26. The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis.
Meng RD; McDonald ER; Sheikh MS; Fornace AJ; El-Deiry WS
Mol Ther; 2000 Feb; 1(2):130-44. PubMed ID: 10933923
[TBL] [Abstract][Full Text] [Related]
27. Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells.
Hao C; Beguinot F; Condorelli G; Trencia A; Van Meir EG; Yong VW; Parney IF; Roa WH; Petruk KC
Cancer Res; 2001 Feb; 61(3):1162-70. PubMed ID: 11221847
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic inactivation of TRAIL decoy receptors at 8p12-21.3 commonly deleted region confers sensitivity to Apo2L/trail-Cisplatin combination therapy in cervical cancer.
Narayan G; Xie D; Ishdorj G; Scotto L; Mansukhani M; Pothuri B; Wright JD; Kaufmann AM; Schneider A; Arias-Pulido H; Murty VV
Genes Chromosomes Cancer; 2016 Feb; 55(2):177-89. PubMed ID: 26542757
[TBL] [Abstract][Full Text] [Related]
29. Pro-apoptotic signaling induced by Retinoic acid and dsRNA is under the control of Interferon Regulatory Factor-3 in breast cancer cells.
Bernardo AR; Cosgaya JM; Aranda A; Jiménez-Lara AM
Apoptosis; 2017 Jul; 22(7):920-932. PubMed ID: 28409399
[TBL] [Abstract][Full Text] [Related]
30. Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2.
Mérino D; Lalaoui N; Morizot A; Schneider P; Solary E; Micheau O
Mol Cell Biol; 2006 Oct; 26(19):7046-55. PubMed ID: 16980609
[TBL] [Abstract][Full Text] [Related]
31. DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells.
Sanlioglu AD; Karacay B; Koksal IT; Griffith TS; Sanlioglu S
Cancer Gene Ther; 2007 Dec; 14(12):976-84. PubMed ID: 17853923
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of preventive and therapeutic activity of novel non-steroidal anti-inflammatory drug, CG100649, in colon cancer: Increased expression of TNF-related apoptosis-inducing ligand receptors enhance the apoptotic response to combination treatment with TRAIL.
Woo JK; Kang JH; Jang YS; Ro S; Cho JM; Kim HM; Lee SJ; Oh SH
Oncol Rep; 2015 Apr; 33(4):1947-55. PubMed ID: 25672292
[TBL] [Abstract][Full Text] [Related]
33. Trailing TRAIL Resistance in Human Breast Adenocarcinoma Cells with Trichostatin A and Zebularine.
Wong SHM; Fang CM; Loh HS; Ngai SC
Anticancer Agents Med Chem; 2023; 23(7):817-831. PubMed ID: 36380402
[TBL] [Abstract][Full Text] [Related]
34. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.
Liu X; Yue P; Khuri FR; Sun SY
Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375
[TBL] [Abstract][Full Text] [Related]
35. Hepatocyte expression of TRAIL pathway regulators correlates with histopathological and clinical parameters in chronic HCV infection.
Brost S; Zimmermann A; Koschny R; Sykora J; Stremmel W; Schirmacher P; Walczak H; Ganten TM
Pathol Res Pract; 2014 Feb; 210(2):83-91. PubMed ID: 24268735
[TBL] [Abstract][Full Text] [Related]
36. Notch inhibition restores TRAIL-mediated apoptosis via AP1-dependent upregulation of DR4 and DR5 TRAIL receptors in MDA-MB-231 breast cancer cells.
Portanova P; Notaro A; Pellerito O; Sabella S; Giuliano M; Calvaruso G
Int J Oncol; 2013 Jul; 43(1):121-30. PubMed ID: 23686163
[TBL] [Abstract][Full Text] [Related]
37. Expression of TNF-related apoptosis-inducing Ligand receptors and antitumor tumor effects of TNF-related apoptosis-inducing Ligand in human hepatocellular carcinoma.
Chen XP; He SQ; Wang HP; Zhao YZ; Zhang WG
World J Gastroenterol; 2003 Nov; 9(11):2433-40. PubMed ID: 14606071
[TBL] [Abstract][Full Text] [Related]
38. The potential evasion of immune surveillance in mucosa associated lymphoid tissue lymphoma by DcR2-mediated up-regulation of nuclear factor-κB.
Anees M; Horak P; Schiefer AI; Vaňhara P; El-Gazzar A; Perco P; Kiesewetter B; Müllauer L; Streubel B; Raderer M; Krainer M
Leuk Lymphoma; 2015 May; 56(5):1440-9. PubMed ID: 25248880
[TBL] [Abstract][Full Text] [Related]
39. Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-independent up-regulation of death receptors: evidence for the role of reactive oxygen species and JNK.
Prasad S; Yadav VR; Kannappan R; Aggarwal BB
J Biol Chem; 2011 Feb; 286(7):5546-57. PubMed ID: 21156789
[TBL] [Abstract][Full Text] [Related]
40. TRAIL upregulates decoy receptor 1 and mediates resistance to apoptosis in insulin-secreting INS-1 cells.
Kang S; Park SY; Lee HJ; Yoo YH
Biochem Biophys Res Commun; 2010 Jun; 396(3):731-5. PubMed ID: 20451496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
